Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus
The investigation of biomarkers for metabolic diseases such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatohepatitis (MASH) reveals their potential for advancing disease treatment and addressing their notable overlap. The connection between MASH, obesity, and T2DM high...
Saved in:
| Main Authors: | Sulagna Mukherjee, Seung-Soon Im |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/2/359 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis
by: Celine I. Wittke, et al.
Published: (2025-07-01) -
Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning
by: Ying Geng, et al.
Published: (2024-11-01) -
Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease
by: Sheetalnath Rooge, et al.
Published: (2025-03-01) -
Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis
by: J. Jose Corbalan, et al.
Published: (2024-12-01) -
Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
by: Alia Hadefi, et al.
Published: (2025-01-01)